Position in APGE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$74,902,987
-$293,399,931 QoQ
Shares Held
564,326
-87.1% QoQ
Ownership
0.746%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 285 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 80%
None 20%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. APGE ranks #40 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in APGE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,902,987 | 564,326 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $74,902,989 | 564,326 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $368,302,918 | 4,375,703 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $358,272,233 | 4,746,585 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $187,672,637 | 4,723,701 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $165,281,982 | 3,805,710 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $204,947,767 | 5,485,754 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $204,636,541 | 4,517,363 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $282,797,854 | 4,814,400 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $139,572,440 | 3,546,949 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $150,834,653 | 2,269,897 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $44,465,895 | 1,591,478 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $33,797,327 | 1,586,729 | Shares | Defined | 2023-12-01 | |
| No filing history on record for this holder in this stock. | ||||||